National Research Council Canada-NRC

National Research Council Canada-NRC

October 03, 2014 11:09 ET

NRC Announces Three Research Programs to Improve the Health of Canadians

Getting new medicines for Canadians on the market faster

MONTREAL, QUEBEC--(Marketwired - Oct. 3, 2014) - In an effort to improve health outcomes for Canadians affected by diseases such as cancer and Alzheimer's, the National Research Council of Canada is announcing three research programs to help industry get new medicines on the market faster.

From discovery up to clinical trials, the National Research Council will contribute to accelerating the development of new therapeutics and vaccines in collaboration with Canadian and international partners. Research will also focus on delivering therapeutics to the brain, to address diseases of the central nervous system. NRC's bioprocessing technologies, which enable the production of biologics and vaccines, will be transferred to Canadian contract manufacturing organizations to strengthen the biomanufacturing sector.

Quick Facts

  • The Biologics research program helps companies develop large molecule medicines to address various types of cancers, as well as inflammatory, infectious, and autoimmune diseases.
  • The Vaccines research program co-develops vaccines for infectious and chronic diseases by addressing four main areas: influenza; pneumonia; infectious diseases affecting high-risk populations including Northern Canadian communities; and cancer.
  • The Therapeutics beyond brain barriers research program works with Canadian enterprises to target various brain diseases by enabling the delivery of large molecule therapies across the blood-brain barrier - a major hurdle in the development of effective therapies.
  • By working with NRC, Canadian companies have access to over 300 scientists and experts - the largest biologics-dedicated research and development team in the country - and state-of-the-art facilities.


"Our mission is to provide innovative technologies and expertise to Canadian industry, enabling them to develop new treatments to prevent or treat diseases cost effectively. Through our research programs, we aim to contribute to a healthier Canada and increase the success of Canadian biotech companies."

Julie Ducharme, General Manager of Human Health Therapeutics at the National Research Council of Canada

Additional Links

Contact Information

  • Media Relations Team
    National Research Council of Canada
    1-855-282-1637 (24/7)
    Twitter: @nrc_cnrc